Resmed (RMD) Receivables (2010 - 2026)

Resmed (RMD) has 17 years of Receivables data on file, last reported at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 9.01% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 9.01% YoY), and the FY2025 full-year result was $990.7 million, up 13.16% from the prior year.
• Receivables for Q1 2026 stood at $1.0 billion, roughly flat from $1.0 billion in the prior quarter.
• Across five years, Receivables topped out at $1.0 billion in Q4 2025 and bottomed at $534.2 million in Q1 2022.
• The 5-year median for Receivables is $817.2 million (2024), against an average of $815.9 million.
• The widest annual swing landed in 2022, when Receivables slipped 3.77%; it then surged 33.31% in 2023.
• A 5-year view of Receivables shows it stood at $695.4 million in 2022, then advanced by 9.91% to $764.3 million in 2023, then climbed by 18.66% to $907.0 million in 2024, then increased by 15.45% to $1.0 billion in 2025, then dropped by 0.11% to $1.0 billion in 2026.
• The last three Receivables figures came in at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $958.4 million (Q3 2025), per Business Quant data.

Peer Comparison